Literature DB >> 26232426

Regulatory Dendritic Cells Restrain NK Cell IFN-γ Production through Mechanisms Involving NKp46, IL-10, and MHC Class I-Specific Inhibitory Receptors.

Raúl G Spallanzani1, Nicolás I Torres1, Damián E Avila2, Andrea Ziblat1, Ximena L Raffo Iraolagoitia1, Lucas E Rossi1, Carolina I Domaica1, Mercedes B Fuertes3, Gabriel A Rabinovich4, Norberto W Zwirner5.   

Abstract

Cross-talk between mature dendritic cells (mDC) and NK cells through the cell surface receptors NKp30 and DNAM-1 leads to their reciprocal activation. However, the impact of regulatory dendritic cells (regDC) on NK cell function remains unknown. As regDC constrain the immune response in different physiological and pathological conditions, the aim of this work was to investigate the functional outcome of the interaction between regDC and NK cells and the associated underlying mechanisms. RegDC generated from monocyte-derived DC treated either with LPS and dexamethasone, vitamin D3, or vitamin D3 and dexamethasone instructed NK cells to secrete lower amounts of IFN-γ than NK cells exposed to mDC. Although regDC triggered upregulation of the activation markers CD69 and CD25 on NK cells, they did not induce upregulation of CD56 as mDC, and silenced IFN-γ secretion through mechanisms involving insufficient secretion of IL-18, but not IL-12 or IL-15 and/or induction of NK cell apoptosis. Blocking experiments demonstrated that regDC curb IFN-γ secretion by NK cells through a dominant suppressive mechanism involving IL-10, NK cell inhibitory receptors, and, unexpectedly, engagement of the activating receptor NKp46. Our findings unveil a previously unrecognized cross-talk through which regDC shape NK cell function toward an alternative activated phenotype unable to secrete IFN-γ, highlighting the plasticity of NK cells in response to tolerogenic stimuli. In addition, our findings contribute to identify a novel inhibitory role for NKp46 in the control of NK cell function, and have broad implications in the resolution of inflammatory responses and evasion of antitumor responses.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26232426     DOI: 10.4049/jimmunol.1403161

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Cutting Edge: Check Your Mice-A Point Mutation in the Ncr1 Locus Identified in CD45.1 Congenic Mice with Consequences in Mouse Susceptibility to Infection.

Authors:  Youngsoon Jang; Zachary J Gerbec; Taejoon Won; Bongkum Choi; Amy Podsiad; Bethany B Moore; Subramaniam Malarkannan; Yasmina Laouar
Journal:  J Immunol       Date:  2018-02-09       Impact factor: 5.422

2.  Downregulation of the Syk Signaling Pathway in Intestinal Dendritic Cells Is Sufficient To Induce Dendritic Cells That Inhibit Colitis.

Authors:  Long Hang; Arthur M Blum; Sangeeta Kumar; Joseph F Urban; Makedonka Mitreva; Timothy G Geary; Armando Jardim; Mary M Stevenson; Clifford A Lowell; Joel V Weinstock
Journal:  J Immunol       Date:  2016-08-24       Impact factor: 5.422

3.  The expression and clinical value of tumor infiltrating dendritic cells in tumor tissues of patients with esophageal cancer.

Authors:  Yanzhi Pei; Yanzhi Zhu; Xiaolin Wang; Lin Xu
Journal:  J Gastrointest Oncol       Date:  2021-10

4.  Immunosuppressive properties of human PD-1 + , PDL-1 + and CD80 + dendritic cells from lymph nodes aspirates of lung cancer patients.

Authors:  Iwona Kwiecień; Elżbieta Rutkowska; Agata Raniszewska; Rafał Sokołowski; Joanna Bednarek; Karina Jahnz-Różyk; Piotr Rzepecki; Joanna Domagała-Kulawik
Journal:  Cancer Immunol Immunother       Date:  2022-03-07       Impact factor: 6.630

Review 5.  CD56 in the Immune System: More Than a Marker for Cytotoxicity?

Authors:  Heleen H Van Acker; Anna Capsomidis; Evelien L Smits; Viggo F Van Tendeloo
Journal:  Front Immunol       Date:  2017-07-24       Impact factor: 7.561

6.  Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production.

Authors:  Amanda J Lee; Firoz Mian; Sophie M Poznanski; Michele Stackaruk; Tiffany Chan; Marianne V Chew; Ali A Ashkar
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 7.  Recognition and Regulation of T Cells by NK Cells.

Authors:  Katharina Pallmer; Annette Oxenius
Journal:  Front Immunol       Date:  2016-06-24       Impact factor: 7.561

8.  Efficacy of Juzentaihoto for Tumor Immunotherapy in B16 Melanoma Metastasis Model.

Authors:  Shintaro Ishikawa; Takako Ishikawa; Chiaki Tezuka; Kazuhito Asano; Masataka Sunagawa; Tadashi Hisamitsu
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-12       Impact factor: 2.629

9.  Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection.

Authors:  Haijun Li; Naicui Zhai; Zhongfeng Wang; Hongxiao Song; Yang Yang; An Cui; Tianyang Li; Guangyi Wang; Junqi Niu; Ian Nicholas Crispe; Lishan Su; Zhengkun Tu
Journal:  Gut       Date:  2017-09-12       Impact factor: 23.059

Review 10.  Searching for the Transcriptomic Signature of Immune Tolerance Induction-Biomarkers of Safety and Functionality for Tolerogenic Dendritic Cells and Regulatory Macrophages.

Authors:  Juan Navarro-Barriuso; María José Mansilla; Eva M Martínez-Cáceres
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.